Camrelizumab Antibody
Camrelizumab (SHR-1210) is a high-affinity human IgG4-κ anti-PD-1 monoclonal antibody with a 3 nM binding affinity and 0.70 nM IC50 for PD-1/PD-L1 blockade. It demonstrates anti-tumor efficacy and tolerability in research models of cancers like NSCLC, ESCC, and HCC, supporting its investigation in immuno-oncology research.
Product Specifications
Product Name Alternative
PD1, PD-1, PD1/PDL1, PD-1/PD-L1, anti-PD-1, Camrelizumab, Camrelizumab (anti-PD-1), PDL1, PD-L1, SHR-1210, SHR 1210, SHR1210
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
42.9 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.69 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Sp1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
GHITM Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
